International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 7691 - 7708
Published: July 1, 2024
Abstract:
Gene
therapy
aims
to
add,
replace
or
turn
off
genes
help
treat
disease.
To
date,
the
US
Food
and
Drug
Administration
(FDA)
has
approved
14
gene
products.
With
increasing
interest
in
therapy,
feasible
delivery
vectors
are
necessary
for
inserting
new
into
cells.
There
different
kinds
of
including
viral
like
lentivirus,
adenovirus,
retrovirus,
adeno-associated
virus
et
al,
non-viral
naked
DNA,
lipid
vectors,
polymer
nanoparticles,
exosomes
with
viruses
being
most
commonly
used.
Among
them,
concerned
vector
is
(AAV)
because
its
safety,
natural
ability
efficiently
deliver
cells
sustained
transgene
expression
multiple
tissues.
In
addition,
AAV
genome
can
be
engineered
generate
recombinant
(rAAV)
containing
sequences
been
proven
a
safe
vector.
Recently,
rAAV
have
treatment
various
rare
diseases.
Despite
these
approvals,
some
major
limitations
remain,
namely
nonspecific
tissue
targeting
host
immune
response.
Additional
problems
include
neutralizing
antibodies
that
block
delivery,
finite
packaging
capacity,
high
titer
used
per
dose
cost.
deal
challenges,
several
techniques
developed.
Based
on
differences
engineering
methods,
this
review
proposes
three
strategies:
engineering-based
capsid
modification
(capsid
modification),
surface
tethering
through
chemical
conjugation
(surface
tethering),
other
formulations
loaded
(virus
load).
advantages
encountered
strategies
summarized.
Keywords:
engineering,
modification,
tethering,
load,
rational
design,
directed
evolution,
machine
learning
Cell Reports,
Journal Year:
2024,
Volume and Issue:
43(3), P. 113813 - 113813
Published: Feb. 22, 2024
Peptidoglycan
recognition
protein
1
(PGLYRP1)
is
a
pattern-recognition
that
mediates
antibacterial
actions
and
innate
immune
responses.
Its
expression
role
in
neuroinflammatory
conditions
remain
unclear.
We
observed
the
upregulation
of
PGLYRP1
inflamed
human
mouse
spinal
cord
brain,
with
microglia
being
primary
cellular
source.
Experiments
using
recombinant
show
potentiates
reactive
gliosis,
neuroinflammation,
consequent
behavioral
changes
multiple
animal
models
neuroinflammation.
Furthermore,
shRNA-mediated
knockdown
Pglyrp1
gene
attenuates
this
inflammatory
response.
In
addition,
we
identify
triggering
receptor
expressed
on
myeloid
cell-1
(TREM1)
as
an
interaction
partner
demonstrate
promotes
neuroinflammation
through
TREM1-Syk-Erk1/2-Stat3
axis
cultured
glial
cells.
Taken
together,
our
results
reveal
for
microglial
mediator.
Finally,
propose
potential
biomarker
therapeutic
target
various
diseases.
Cold Spring Harbor Perspectives in Biology,
Journal Year:
2024,
Volume and Issue:
16(8), P. a041366 - a041366
Published: March 4, 2024
Amanda
Sierra1,2,3,
Veronique
E.
Miron4,5,6,
Rosa
C.
Paolicelli7
and
Richard
M.
Ransohoff8
1Achucarro
Basque
Center
for
Neuroscience,
Glial
Cell
Biology
Laboratory,
Science
Park
of
UPV/EHU,
E-48940
Leioa,
Bizkaia,
Spain
2Department
Biochemistry
Molecular
Biology,
University
the
Country
EHU/UPV,
48940
3Ikerbasque
Foundation,
Bilbao
48009,
4BARLO
Multiple
Sclerosis
Centre,
Keenan
Research
Centre
Biomedical
at
St.
Michael's
Hospital,
Toronto
M5B
1T8,
Canada
5Department
Immunology,
Toronto,
M5S
1A8,
6UK
Dementia
Institute
Edinburgh,
Edinburgh
BioQuarter,
EH16
4TJ,
United
Kingdom
7Department
Sciences,
Faculty
Medicine,
Lausanne,
CH-1005
Switzerland
8Third
Rock
Ventures,
Boston,
Massachusetts
02215,
USA
Correspondence:
amanda.sierra{at}achucarro.org;
rransohoff{at}thirdrockventures.com
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(10)
Published: March 6, 2024
The
accumulation
of
self-renewed
polarized
microglia
in
the
penumbra
is
a
critical
neuroinflammatory
process
after
ischemic
stroke,
leading
to
secondary
demyelination
and
neuronal
loss.
Although
known
regulate
tumor
cell
proliferation
neuroinflammation,
HDAC3's
role
microgliosis
microglial
polarization
remains
unclear.
We
demonstrated
that
HDAC3
knockout
(HDAC3-miKO)
ameliorated
poststroke
long-term
functional
histological
outcomes.
RNA-seq
analysis
revealed
mitosis
as
primary
affected
HDAC3-deficent
following
stroke.
Notably,
HDAC3-miKO
specifically
inhibited
proinflammatory
without
affecting
anti-inflammatory
microglia,
preventing
transition
state.
Moreover,
ATAC-seq
showed
induced
closing
accessible
regions
enriched
with
PU.1
motifs.
Overexpressing
via
an
AAV
approach
reversed
HDAC3-miKO-induced
inhibition
protective
effects
on
indicating
downstream
molecule
mediates
These
findings
uncovered
HDAC3/PU.1
axis,
which
mediated
differential
proliferation-related
reprogramming
different
populations,
drove
inflammatory
state
transition,
contributed
pathophysiology
Annals of the New York Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
1533(1), P. 38 - 50
Published: Jan. 31, 2024
Abstract
It
has
been
more
than
a
century
since
Pío
del
Río‐Hortega
first
characterized
microglia
in
histological
stains
of
brain
tissue.
Since
then,
significant
advances
have
made
understanding
the
role
these
resident
central
nervous
system
(CNS)
macrophages.
In
particular,
it
is
now
known
that
can
sense
neural
activity
and
modulate
neuronal
circuits
accordingly.
We
review
mechanisms
by
which
detect
changes
to
then
synapse
numbers
developing
mature
CNS.
This
includes
responses
both
spontaneous
experience‐driven
activity.
further
discuss
activity‐dependent
regulate
synaptic
function
circuit
excitability.
Together,
our
discussion
provides
comprehensive
functions
within
healthy
CNS,
highlights
exciting
new
open
questions
related
fully
as
key
components
regulators
circuits.
Redox Biology,
Journal Year:
2024,
Volume and Issue:
70, P. 103064 - 103064
Published: Feb. 2, 2024
Amyloid-beta
(Aβ)
is
a
key
factor
in
the
onset
and
progression
of
Alzheimer's
disease
(AD).
Selenium
(Se)
compounds
show
promise
AD
treatment.
Here,
we
revealed
that
selenoprotein
K
(SELENOK),
involved
immune
regulation
potentially
related
to
pathology,
plays
critical
role
microglial
response,
migration,
phagocytosis.
In
vivo
vitro
studies
corroborated
SELENOK
deficiency
inhibits
Aβ
phagocytosis,
exacerbating
cognitive
deficits
5xFAD
mice,
which
are
reversed
by
overexpression.
Mechanistically,
CD36
palmitoylation
through
DHHC6,
regulating
localization
plasma
membranes
thus
impacting
was
reduced
brains
patients
mice
with
AD.
Se
supplementation
promoted
expression
palmitoylation,
enhancing
phagocytosis
mitigating
progression.
We
have
identified
regulatory
mechanisms
from
Se-dependent
selenoproteins
providing
novel
insights
into
potential
therapeutic
strategies
involving
selenoproteins.
Neuroscience & Biobehavioral Reviews,
Journal Year:
2024,
Volume and Issue:
165, P. 105848 - 105848
Published: Aug. 13, 2024
Microglia,
as
immune
cells
in
the
central
nervous
system,
are
closely
related
to
cognitive
impairment
associated
with
type
2
diabetes
(T2D).
Preliminary
explorations
have
investigated
relationship
between
T2D-related
and
activation
polarization
of
microglia.
This
review
summarizes
potential
mechanisms
microglial
context
T2D.
It
discusses
inflammatory
responses,
neuronal
apoptosis,
amyloid-β
deposition,
abnormal
phosphorylation
Tau
protein
mediated
by
polarization,
exploring
connections
from
multiple
perspectives.
Additionally,
this
provides
references
for
future
treatment
targeting
microglia
clinical
translation.
Glia,
Journal Year:
2023,
Volume and Issue:
71(9), P. 2071 - 2095
Published: May 24, 2023
Insights
into
the
role
astrocytes
and
microglia
play
in
normal
diseased
brain
functioning
has
expanded
drastically
over
last
decade.
Recently,
chemogenetic
tools
have
emerged
as
cutting-edge
techniques,
allowing
targeted
spatiotemporal
precise
manipulation
of
a
specific
glial
cell
type.
As
result,
significant
advances
astrocyte
microglial
function
been
made,
showing
how
cells
can
intervene
central
nervous
system
(CNS)
functions
such
cognition,
reward
feeding
behavior
addition
to
their
established
contribution
diseases,
pain,
CNS
inflammation.
Here,
we
discuss
latest
insights
health
disease
that
made
through
application
chemogenetics.
We
will
focus
on
intracellular
signaling
pathways
induced
by
activation
designer
receptors
exclusively
activated
drugs
(DREADDs)
microglia.
also
elaborate
some
potential
pitfalls
translational
DREADD
technology.
Molecular Therapy — Methods & Clinical Development,
Journal Year:
2023,
Volume and Issue:
31, P. 101102 - 101102
Published: Aug. 29, 2023
The
brain
is
often
described
as
an
"immune-privileged"
organ
due
to
the
presence
of
blood-brain-barrier
(BBB),
which
limits
entry
immune
cells.
In
general,
intracranial
injection
adeno-associated
virus
(AAV)
considered
a
relatively
safe
procedure.
this
study,
we
discovered
that
AAV,
popular
engineered
viral
vector
for
gene
therapy,
can
disrupt
BBB
and
induce
cell
infiltration
in
titer-dependent
manner.
First,
our
bulk
RNA
sequencing
data
revealed
high-titer
AAV
significantly
upregulated
many
genes
involved
disrupting
integrity
antiviral
adaptive
responses.
By
using
histologic
analysis,
further
demonstrated
biological
structure
was
severely
disrupted
adult
mouse
brain.
Meanwhile,
noticed
abnormal
leakage
blood
components,
including
cells,
within
parenchyma
injected
areas.
Moreover,
identified
majority
infiltrated
cells
were
cytotoxic
T
lymphocytes
(CTLs),
resulted
massive
loss
neurons
at
site
injection.
addition,
antagonizing
CTL
function
by
administering
antibodies
reduced
neuronal
toxicity
induced
AAV.
Collectively,
findings
underscore
potential
severe
side
effects
might
compromise
proper
interpretation
if
unaware
of.
Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(35)
Published: Aug. 21, 2023
Tissue
macrophages,
including
microglia,
are
notoriously
resistant
to
genetic
manipulation.
Here,
we
report
the
creation
of
Adeno-associated
viruses
(AAV)
variants
that
efficiently
and
widely
transduce
microglia
tissue
macrophages
in
vivo
following
intravenous
delivery,
with
transgene
expression
up
80%.
We
use
this
technology
demonstrate
manipulation
gene
microglial
ablation,
thereby
providing
invaluable
research
tools
for
study
these
important
cells.